Literature DB >> 17337229

Cat scratch disease during etanercept therapy.

Sylvain Mathieu1, Jean-François Vellin, David Poujol, Jean-Michel Ristori, Martin Soubrier.   

Abstract

Lymphadenopathy in a patient taking TNFalpha antagonist therapy may indicate lymph node tuberculosis or a hematological malignancy. Although histological evidence of granuloma suggests tuberculosis, many other infections responsible for granulomatous reactions have been reported in patients on TNFalpha antagonist therapy. We report a case of granulomatous lymphadenopathy due to Bartonella henselae in a patient taking etanercept to treat ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337229     DOI: 10.1016/j.jbspin.2006.05.017

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  2 in total

1.  [A case of granulomatous rosacea coinciding with the use of etanercept: no relapse with infliximab].

Authors:  U M Winter; R Treudler; U Paasch; M Sticherling; J C Simon
Journal:  Hautarzt       Date:  2008-09       Impact factor: 0.751

Review 2.  Cat scratch disease during infliximab therapy: a case report and literature review.

Authors:  Yi Zhou; Geng Yin; Chunyu Tan; Yi Liu
Journal:  Rheumatol Int       Date:  2014-12-30       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.